IMAX (NYSE:IMAX) Announces Earnings Results, Beats Expectations By $0.15 EPS

Posted by on Jul 23rd, 2026

IMAX (NYSE:IMAX – Get Free Report) posted its earnings results on Thursday. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.28 by $0.15, FiscalAI reports. IMAX had a net margin of 9.08% and a return on equity of 13.61%. The firm had revenue of $102.84 million for the quarter, compared to the consensus estimate of $94.69 million. During the same period in the prior year, the business posted $0.26 earnings per share. The business’s quarterly revenue was up 12.2% on a year-over-year basis.

Here are the key takeaways from IMAX’s conference call:

  • IMAX said Q2 results beat consensus across key metrics, with revenue up 12% to $103 million, adjusted EPS up 65% to $0.43, and adjusted EBITDA of $48 million at a 46.6% margin.
  • The Odyssey is driving extraordinary early box office performance, including a $52 million global opening, 75% domestic occupancy, and record weekday holds, which management says could make 2026 box office a record year for IMAX.
  • Management highlighted a strong content pipeline for the back half of 2026 and into 2027, led by Dune: Part Three, Spider-Man: Brand New Day, and several other Filmed for IMAX and IMAX 70mm titles that could extend momentum.
  • Exhibitor demand remains strong, with 38 system installations in Q2 and 36 system signings, while year-to-date signings reached 62, supporting continued global network expansion.
  • IMAX is also pushing newer growth initiatives such as merchandising and an in-vehicle entertainment partnership in China, which management views as untapped opportunities but still early-stage.

IMAX Trading Up 10.7%

IMAX traded up $4.19 on Thursday, hitting $43.49. 2,640,596 shares of the stock traded hands, compared to its average volume of 1,131,107. The business has a fifty day moving average price of $39.60 and a two-hundred day moving average price of $37.94. The firm has a market capitalization of $2.39 billion, a PE ratio of 66.81, a P/E/G ratio of 1.39 and a beta of 0.37. IMAX has a 52 week low of $24.20 and a 52 week high of $45.52.

Insider Buying and Selling at IMAX

In other news, CEO Richard L. Gelfond sold 8,943 shares of the business’s stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $37.33, for a total transaction of $333,842.19. Following the sale, the chief executive officer directly owned 765,002 shares in the company, valued at approximately $28,557,524.66. The trade was a 1.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 20.55% of the company’s stock.

Institutional Investors Weigh In On IMAX

A number of institutional investors have recently bought and sold shares of IMAX. Orbis Allan Gray Ltd lifted its position in shares of IMAX by 31.7% during the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock worth $142,960,000 after buying an additional 1,230,267 shares during the period. Balyasny Asset Management L.P. acquired a new stake in IMAX in the 2nd quarter valued at $12,568,000. Nuveen LLC grew its position in IMAX by 253.0% in the fourth quarter. Nuveen LLC now owns 507,377 shares of the company’s stock valued at $18,753,000 after acquiring an additional 363,658 shares during the period. BNP Paribas Financial Markets grew its position in IMAX by 494.6% in the third quarter. BNP Paribas Financial Markets now owns 377,207 shares of the company’s stock valued at $12,354,000 after acquiring an additional 313,763 shares during the period. Finally, Squarepoint Ops LLC raised its stake in IMAX by 177.0% during the second quarter. Squarepoint Ops LLC now owns 446,286 shares of the company’s stock worth $12,478,000 after acquiring an additional 285,184 shares in the last quarter. Institutional investors and hedge funds own 93.51% of the company’s stock.

More IMAX News

Here are the key news stories impacting IMAX this week:

  • Positive Sentiment: IMAX beat second-quarter expectations, reporting EPS of $0.43 versus the $0.28 consensus and revenue of $102.84 million versus $94.69 million expected. The company also posted 12.2% year-over-year revenue growth, reinforcing momentum in its core business. Article Title
  • Positive Sentiment: Management highlighted The Odyssey as a potentially “transformational” event for IMAX, with the film’s debut already generating unusually strong IMAX ticket sales and broad media attention around the company’s 70mm and premium-large-format exposure. Article Title
  • Positive Sentiment: Heavy call-option activity suggests traders are positioning for more upside, with call volume jumping well above normal levels. That kind of activity often signals bullish sentiment around a stock’s near-term outlook.
  • Neutral Sentiment: Several articles focused on the record-breaking opening weekend for The Odyssey, including strong IMAX ticket participation and premium-screen demand. These stories are supportive for the brand, but they are more indirect than the earnings results in terms of immediate stock impact.
  • Neutral Sentiment: Rosenblatt Securities reiterated a “Buy” rating, which adds a favorable analyst backdrop, though it is not as market-moving as the quarterly beat.

Analyst Ratings Changes

A number of research analysts recently weighed in on IMAX shares. Weiss Ratings raised IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, July 16th. The Goldman Sachs Group set a $40.00 price objective on shares of IMAX in a research note on Thursday, July 9th. B. Riley Financial reiterated a “buy” rating on shares of IMAX in a research note on Monday. Benchmark restated a “buy” rating on shares of IMAX in a report on Monday, June 22nd. Finally, Roth Capital reaffirmed a “buy” rating and issued a $48.00 price target on shares of IMAX in a research report on Thursday. Nine investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $47.90.

View Our Latest Stock Report on IMAX

IMAX Company Profile

(Get Free Report)

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.

Read More

Earnings History for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.